IV Therapy in Korea — Glutathione, Vitamin & Stem Cell Infusions at Incheon Airport

Intravenous Bioavailability: The Fundamental Advantage

The primary scientific rationale for IV therapy is bioavailability — the fraction of an administered compound that reaches systemic circulation in an unchanged, biologically active form. Oral administration of most vitamins and antioxidants is limited by intestinal absorption capacity, first-pass hepatic metabolism, and gastrointestinal degradation. Glutathione exemplifies this limitation: Witschi et al. (1992) demonstrated that oral glutathione supplementation at 3,000mg produced no statistically significant increase in plasma glutathione levels due to rapid hydrolysis by gamma-glutamyltranspeptidase (GGT) in the intestinal brush border and hepatic first-pass metabolism. Intravenous administration bypasses both barriers, delivering 100% of the administered dose to the bloodstream. For vitamin C, Padayatty et al. (2004) showed that IV infusion achieves plasma concentrations 25-70 times higher than maximally tolerated oral doses — reaching levels at which vitamin C exhibits pharmacological effects (antioxidant, pro-collagen, immunomodulatory) that are simply unattainable through oral supplementation regardless of dose.

Witschi A, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992;43(6):667-669. doi:10.1007/BF02284971

Glutathione IV: Antioxidant Defense and Skin Brightening

Glutathione (gamma-L-glutamyl-L-cysteinyl-glycine, GSH) is the body’s primary intracellular antioxidant, present in every mammalian cell at concentrations of 1-10 millimolar. Beyond direct ROS scavenging, glutathione serves as a cofactor for glutathione peroxidase and glutathione S-transferase — critical enzymes in the Phase II hepatic detoxification pathway. For skin brightening, glutathione modulates melanogenesis through three mechanisms: direct tyrosinase inhibition via copper chelation, diversion of melanin synthesis from eumelanin (dark) to pheomelanin (light), and reduction of oxidative stress-driven melanocyte hyperactivity. Arjinpathana and Asawanonda (2012) demonstrated in a randomized, double-blind, placebo-controlled trial that even oral glutathione (500mg twice daily for 4 weeks) produced statistically significant melanin index reduction (p = 0.003) at all measured anatomical sites. Given that IV administration achieves 20-30 times higher bioavailability, the brightening effects of IV glutathione are expected to be correspondingly more substantial.

Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012;23(2):97-102. doi:10.3109/09546631003801619

Autologous Blood Therapy: Concentrated Regenerative Factors

Autologous blood therapy (including platelet-rich plasma, PRP) harnesses the body’s own regenerative capacity for tissue rejuvenation. The therapeutic mechanism centers on concentrated platelets, which release over 30 bioactive growth factors upon activation — including PDGF (platelet-derived growth factor), TGF-beta (transforming growth factor), VEGF (vascular endothelial growth factor), and EGF (epidermal growth factor). These factors stimulate fibroblast proliferation, collagen synthesis, angiogenesis, and extracellular matrix remodeling in treated tissues. Redaelli et al. (2010) demonstrated that PRP injections for facial rejuvenation produced measurable improvements in skin thickness, elasticity, and wrinkle depth. The EVER YOUTH protocol at RE:BERRY extends this approach by combining autologous blood-derived factors with proprietary Eternal Booster ampoules containing additional regenerative compounds, and offering multiple application routes (face, scalp, IV) to target specific aging concerns. The autologous nature of the therapy eliminates allergic reaction risk and represents a paradigm shift from synthetic to biologically derived anti-aging treatment.

Redaelli A, Romano D, Marcianò A. Face and neck revitalization with platelet-rich plasma (PRP): clinical outcome in a series of 23 consecutively treated patients. J Drugs Dermatol. 2010;9(5):466-472.

High-Dose Vitamin C: Pharmacological vs. Nutritional Effects

Vitamin C (ascorbic acid) exemplifies the dose-response difference between oral and IV administration. At standard oral doses (200-500mg), vitamin C functions as a nutritional supplement maintaining collagen synthesis and immune function. At IV doses achieving plasma concentrations of 10-20 millimolar (25-70 times higher than oral maximums), vitamin C exhibits pharmacological properties: potent antioxidant activity capable of regenerating oxidized glutathione back to its reduced active form, pro-collagen gene expression stimulation in fibroblasts, and immunomodulatory effects on T-cell and natural killer cell function. Padayatty et al. (2004) established that oral vitamin C cannot achieve plasma concentrations above 220 micromolar due to saturable intestinal absorption and renal excretion thresholds — while IV infusion routinely achieves 5,000+ micromolar concentrations. This pharmacokinetic reality underpins the clinical rationale for IV vitamin C in aesthetic medicine, post-surgical recovery, immune support, and anti-aging protocols.

Padayatty SJ, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-537. doi:10.7326/0003-4819-140-7-200404060-00010